NeuroGeneces, Inc. — Form D/A
NeuroGeneces, Inc. of Santa Fe, NM, a company, filed a Form D amendment with the SEC on 2019-01-28. The offering totals $1.0M, of which $130K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-01-28
- Form: D/A
- Accession: 0001716111-19-000001
- Industry: Biotechnology
- Exemptions: 04, 06b, 4a5
- Total offering: $1.0M
- Amount sold: $130K
- Remaining: $870K
- Minimum investment: $1
- Investors: 4
- Date of first sale: 2018-01-01
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-294428
Issuer
- Name: NeuroGeneces, Inc.
- CIK: 0001716111
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 1012 Marquez Place #207A, Santa Fe, NM, 87505
- Phone: 505-780-8628
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Karen Crow | Director | Santa Fe, NM |
| Barry Jason Worchel | Director | Santa Fe, NM |
| Karen Crow | Executive Officer | Santa Fe, NM |
| Barry Jason Worchel | Executive Officer | Santa Fe, NM |
| Karen Crow | Promoter | Santa Fe, NM |
| Barry Jason Worchel | Promoter | Santa Fe, NM |
| Barry Jason Worchel | Related Person | Santa Fe, NM |
| Karen Crow | Related Person | Santa Fe, NM |
Other filings by this issuer (3)
More